CDSCO Panel approves Biological E's Phase IV clinical trial protocol to study PNEUBEVAX-14 Dr. Divya Colin27 Oct 2024 5:30 PM ISTNew Delhi: The vaccine major Biological E has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Submit Immunogenicity Data: CDSCO Panel Tells Pfizer on Pneumococcal Polysaccharide Conjugate Vaccine study Dr. Divya Colin12 Aug 2024 6:00 PM ISTNew Delhi: Reviewing the Phase III clinical trial report of the 20 valent Pneumococcal Conjugate Vaccine (20vPnC) presented by Pfizer, the Subject...
Aurobindo Pharma JV Tergene gets CDSCO panel recommendation for 15-valent Pneumococcal Polysaccharide Conjugate Vaccine Ruchika Sharma27 Dec 2022 3:42 PM ISTHyderabad: Drugmaker, Aurobindo Pharma Ltd, has announced that Subject Expert Committee (SEC) of the Central Drugs StandardControl Organization...
SII gets CDSCO panel nod to study Pneumococcal Polysaccharide Conjugate Vaccine,Adsorbed,10-Valent Dr. Divya Colin21 Oct 2022 6:00 PM ISTNew Delhi: Serum Institute of India has got a go-ahead from the Subject Expert Committee (SEC) functional under Central Drug Standard Control...
CDSCO panel seeks justification for Pfizer Phase III CT of 20-Valent Pneumococcal Conjugate Vaccine Dr. Divya Colin11 Sept 2022 11:35 AM ISTNew Delhi: In response to the drug major Pfizer's Phase III clinical trial proposal for Pneumococcal Polysaccharide Conjugate Vaccine (20 Valent), the...
Exemption to SII pneumococcal vaccine from price control for 5 years: NPPA Susmita Roy18 April 2022 5:49 PM ISTNew Delhi: In a major relief to Serum Institute of India, the drug price regulator, the National Pharmaceutical Pricing Authority (NPPA), has...
FIRST: Serum Institute to launch its indigenous pneumonia vaccine next week Ruchika Sharma25 Dec 2020 10:56 AM ISTThe vaccine is used for active immunisation against invasive disease and pneumonia caused by "Streptococcus pneumonia" in infants, the health ministry...
DCGI approves India first fully indigenously developed vaccine against pneumonia Farhat Nasim16 July 2020 1:00 PM ISTThe ministry said the vaccine will be used for active immunization against invasive disease and pneumonia caused by ''Streptococcus pneumonia'' among...
